Small Molecule Penalty

Sep 26

Small Molecules, Big Impact One Pager

Sep 20

Looking back and looking ahead: A momentous (and misguided) time for drug pricing policy

August was a momentous month for the life sciences ecosystem, and September looks to be just as significant. In this blog post, we want...

Sep 9

Incubate launches "Small Molecules, Big Voices" series to highlight the value of small molecule drugs

Today, Incubate launched the "Small Molecules, Big Voices" video series to illustrate the importance of small molecule drugs to patients,...

Jun 12

Incubate Launches Life Science Investment Tracker to Analyze Impact of the Inflation Reduction Act

WASHINGTON (June 13) -- Today, Incubate launched the Life Science Investment Tracker, a database monitoring changes in investment,...

Mar 11

From Idea To Prescription: Bringing A Drug To Market

Bringing a new drug to market is a complex and lengthy process that involves multiple phases of research, development, testing, and...

Dec 7, 2023

Incubate Participates In Pulse Webinar

Discussion on the vital role of M&A in bringing the next generation of biopharmaceutical breakthroughs to patients. Featured guests...

Oct 11, 2023

Mary R. Grealy On The Small Molecule Penalty, U.S. Dominance In Life Sciences, And More

Incubate Executive Director John Stanford sat down this week with Mary R. Grealy, CEO of the Healthcare Leadership Council, to discuss...

Sep 12, 2023

The Small Molecule Penalty: Explained By Incubate

Dec 15, 2022

The Inflation Reduction Act- Explained By Incubate

Incubate breaks down the Inflation Reduction Act, diving into implications and potential impacts on life science development. Keep up...

Jun 10, 2021

The Pathway To Drug Development Driven By Private Capital

Video narrated by Sara Nayeem, Avoro Ventures